Kimberly Davis, RPh, MS

Takeda Development Center Americas, Inc.

Disclosure(s): Takeda: Employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-2313) Multinational, Retrospective Study Assessing Outcomes and Healthcare Resource Utilization in Hematopoietic Stem Cell Transplant Recipients with Cytomegalovirus Infection and Refractory, Resistance, or Intolerance to Anti-Cytomegalovirus Treatments: Analysis of Impact of Viremia Clearance on Outcomes
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT